203 related articles for article (PubMed ID: 9303983)
21. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
[TBL] [Abstract][Full Text] [Related]
22. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
[TBL] [Abstract][Full Text] [Related]
23. In vitro diagnosis of chronic nasal inflammation.
Kramer MF; Burow G; Pfrogner E; Rasp G
Clin Exp Allergy; 2004 Jul; 34(7):1086-92. PubMed ID: 15248854
[TBL] [Abstract][Full Text] [Related]
24. Concentration, distribution and expression of interleukin-5 in human nasal polyp tissues.
Xu R; Li Y; Xie M; Xu G; Zhang G; Wang S
Chin Med J (Engl); 2002 Sep; 115(9):1386-9. PubMed ID: 12411119
[TBL] [Abstract][Full Text] [Related]
25. Protease-dependent activation of nasal polyp epithelial cells by airborne fungi leads to migration of eosinophils and neutrophils.
Shin SH; Lee YH; Jeon CH
Acta Otolaryngol; 2006 Dec; 126(12):1286-94. PubMed ID: 17101590
[TBL] [Abstract][Full Text] [Related]
26. Eosinophil adhesion regulates RANTES production in nasal epithelial cells.
Terada N; Maesako K; Hamano N; Houki G; Ikeda T; Sai M; Yamashita T; Fukuda S; Wakita A; Yoshimura K; Konno A
J Immunol; 1997 Jun; 158(11):5464-70. PubMed ID: 9164969
[TBL] [Abstract][Full Text] [Related]
27. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
[TBL] [Abstract][Full Text] [Related]
28. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps.
Mullol J; Xaubet A; Gaya A; Roca-Ferrer J; López E; Fernàndez JC; Fernàndez MD; Picado C
Clin Exp Allergy; 1995 Jul; 25(7):607-15. PubMed ID: 8521179
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of nasal polyp mast cell and eosinophil activation by desloratadine.
Kowalski ML; Lewandowska A; Wozniak J; Makowska J; Jankowski A; DuBuske L
Allergy; 2005 Jan; 60(1):80-5. PubMed ID: 15575935
[TBL] [Abstract][Full Text] [Related]
30. Eosinophilic cationic protein as a marker of nasal inflammation in patients with cystic fibrosis.
Weber A; Kiefer J; Peters S; Schneider M; Bargon J; May A
Laryngoscope; 1999 Oct; 109(10):1696-702. PubMed ID: 10522945
[TBL] [Abstract][Full Text] [Related]
31. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
[TBL] [Abstract][Full Text] [Related]
32. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma.
Michaëlsson G; Kraaz W; Gerdén B; Hagforsen E; Lundin IP; Lööf L; Sj-oberg O; Scheynius A
Br J Dermatol; 1996 Sep; 135(3):371-8. PubMed ID: 8949428
[TBL] [Abstract][Full Text] [Related]
33. [Effect of eosinophil major basic protein on histamine release from nasal epithelial mast cells].
Xiao S; Okuda M
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Aug; 32(4):201-4. PubMed ID: 10743163
[TBL] [Abstract][Full Text] [Related]
34. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
35. Injurious effect of eosinophil extract on the human nasal mucosa.
Liu CM; Okuda M
Rhinology; 1988 Jun; 26(2):121-32. PubMed ID: 3175456
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of chronic sinus diseases by measurement of inflammatory mediators.
Van Zele T; Claeys S; Gevaert P; Van Maele G; Holtappels G; Van Cauwenberge P; Bachert C
Allergy; 2006 Nov; 61(11):1280-9. PubMed ID: 17002703
[TBL] [Abstract][Full Text] [Related]
37. Taurine chloramine inhibits functional responses of human eosinophils in vitro.
Martinez-Losa M; Cortijo J; Piqueras L; Sanz MJ; Morcillo EJ
Clin Exp Allergy; 2009 Apr; 39(4):537-46. PubMed ID: 19222497
[TBL] [Abstract][Full Text] [Related]
38. [Infiltration and activation of eosinophils during the late phase response in subjects with nasal allergy--from a study of nasal lavage fluid].
Terada N; Ito E; Sugiyama T; Togawa K; Konno A
Arerugi; 1991 Mar; 40(3 Pt 1):181-90. PubMed ID: 2053856
[TBL] [Abstract][Full Text] [Related]
39. Rhinovirus-infected nasal polyp epithelial cells: effect on the activation and migration of eosinophils by airborne fungi.
Jang YJ; Lee YH; Shin SH
Ann Allergy Asthma Immunol; 2010 May; 104(5):434-9. PubMed ID: 20486335
[TBL] [Abstract][Full Text] [Related]
40. [The role of eosinophil in nasal allergy].
Yoshimi R
Nihon Rinsho; 1993 Mar; 51(3):820-4. PubMed ID: 8492464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
